Artemisinin Cocrystals for Bioavailability Enhancement. Part 2:
PBPK modeling
artemisinin
parasitaemia
pharmaceutical cocrystal
pharmacokinetics
Journal
Molecular pharmaceutics
ISSN: 1543-8392
Titre abrégé: Mol Pharm
Pays: United States
ID NLM: 101197791
Informations de publication
Date de publication:
06 12 2021
06 12 2021
Historique:
pubmed:
9
11
2021
medline:
15
3
2022
entrez:
8
11
2021
Statut:
ppublish
Résumé
We report the evaluation and prediction of the pharmacokinetic (PK) performance of artemisinin (ART) cocrystal formulations, that is, 1:1 artemisinin/orcinol (ART-ORC) and 2:1 artemisinin/resorcinol (ART
Identifiants
pubmed: 34748332
doi: 10.1021/acs.molpharmaceut.1c00385
doi:
Substances chimiques
Artemisinins
0
artemisinin
9RMU91N5K2
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM